InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,309.34
(
0.02%
)
US TECH 100
18,180.40
(
-0.09%
)
Dow Jones
39,845.96
(
0.10%
)
Brent Oil
82.41
(
-1.35%
)
Bitcoin
69,757.29
(
-2.37%
)
Post# of 251871
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119665
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 200628

Monday, 10/17/2016 4:17:47 PM

Monday, October 17, 2016 4:17:47 PM

Post# of 251871
(JNJ)—PFE launching US Remicade FoB in November ~15% discount:

http://finance.yahoo.com/news/pfizer-announces-u-availability-biosimilar-200500747.html

INFLECTRA will be introduced at a 15% discount to the current wholesaler acquisition cost (WAC) of REMICADE, its reference product. WAC is not inclusive of discounts to payers, providers, distributors and other purchasing organizations.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up